Amcor's Jefferies Presentation Highlights Integration and Regulatory Challenges; Potential Sell Stance Maintained

What happened

Amcor management presented at the Jefferies Global Industrials Conference on September 10, 2026, likely providing an update on the Berry integration and strategic priorities. The latest 10-K, 10-Q, and proxy statements reveal a company wrestling with high leverage (net debt/EBITDA ~8x, interest coverage ~2.5x) and compressed GAAP margins (~6.7% vs ~10% in 2023) following the all-stock Berry merger. Management continues to target $650 million in cumulative synergies by FY28, but execution risk remains elevated given the complexity of combining two large packaging firms. Regulatory headwinds from single-use plastic bans, PFAS restrictions, and plastic taxes threaten legacy profit pools and add to uncertainty around the $2.5 billion sales strategic review. The stock trades at ~21x TTM EPS and ~58% above a conservative DCF estimate of $5.28 per share, suggesting the market is pricing in substantial synergy success despite limited margin of safety.

Implication

Investors should closely track progress against the $650 million synergy target and watch for clear evidence of margin recovery toward high-single-digits, as any shortfall would likely pressure the stock further. The strategic review of ~$2.5 billion in sales, including North American Beverage, could unlock value if assets are divested at accretive multiples, but distressed sales would reinforce the bear case. Balance sheet health is critical: net debt/EBITDA must trend down toward 4-5x, and interest coverage must improve to alleviate solvency concerns and preserve investment-grade ratings. Regulatory developments, particularly PFAS restrictions and plastic taxes, may force costly reformulations and capex, further compressing free cash flow and challenging the dividend. Until there is visible progress on deleveraging and margin repair, new capital is better deployed elsewhere, and existing holders should consider reducing exposure given the limited margin of safety.

Thesis delta

The conference presentation does not alter the fundamental bearish view but may provide incremental color on integration progress and portfolio actions. The investment thesis remains cautious, with key watch items being synergy delivery, strategic divestitures, and deleveraging. No material shift from the prior potential sell judgment unless management presented new evidence of substantially improved margins or faster deleveraging.